Related Experiment Videos
Stimulation of human prolactin secretion by mescaline
Psychopharmacology
|September 1, 1979
Summary
Mescaline significantly increases prolactin (PRL) and growth hormone (GH) secretion in humans. The non-hallucinogenic compound 2,3,4-TMPEA did not affect these hormone levels.
Area of Science:
- Endocrinology
- Neuropharmacology
Background:
- Prolactin (PRL) and Growth Hormone (GH) are key pituitary hormones.
- Understanding the effects of psychoactive substances on endocrine function is crucial.
Purpose of the Study:
- To investigate the impact of mescaline and a related non-hallucinogenic compound on human PRL and GH secretion.
- To differentiate the endocrine effects of mescaline from its structural analog.
Main Methods:
- Oral administration of 5 mg/kg mescaline or 2,3,4-TMPEA to human subjects.
- Measurement of serum Prolactin (PRL) and Growth Hormone (GH) concentrations over time.
Main Results:
- Mescaline administration led to a >4-fold increase in serum PRL, peaking at 90-120 minutes post-ingestion.
- Sustained elevation of serum PRL was observed up to 5 hours after mescaline intake.
- Mescaline also stimulated Growth Hormone (GH) secretion.
- No significant alterations in serum PRL or GH were detected after administration of 2,3,4-TMPEA.
Conclusions:
- Mescaline potently stimulates both Prolactin and Growth Hormone secretion in humans.
- The hallucinogenic properties of mescaline may be linked to its observed endocrine effects.
- The non-hallucinogenic analog 2,3,4-TMPEA does not share these endocrine-stimulating properties.